Trade Share CFDs on the powerful Capital-infusions MetaTrader 5 platform
Access and trade ASX, NYSE, Nasdaq and HKEX Share CFDs with leverage up to 20:1.
You can start trading shares with as little as $200 and control a position of $4,000 on some of the most popular shares globally, including Apple, Google, Facebook and many more.
▶ Trade anytime, anywhere
At home? On the go? Capital-infusions has you covered with dedicated platforms for Windows, Mac, iOS and Android.
▶ Global markets at your fingertips
Trade 200+ ASX shares, 80+NYSE, NASDAQ and HKEX shares all from one account.
▶ Access leverage up to 20:1
Leverage allows you to control a larger position size with a smaller initial investment.
▶ Trade long and short
Traditional share trading doesn’t allow you to trade short, but with Capital-infusions Share CFDs, even bearish trends can be capitalised on.
▶ Ultra-fast execution speed
We work tirelessly to ensure fast execution speeds across our entire product range.
▶ 24/5 dedicated client support
Each client is assigned a dedicated account manager. For Indonesian and Chinese speakers, we have additional account managers who speak your language.
▶ Diversify your portfolio with 300+ markets
Capital-infusions also provides a wide variety of Forex Pairs, Indices and Commodities to trade as CFDs.
Share CFDs, or Share CFD trading, creates a unique opportunity to speculate on the share price movements of publicly listed companies traded on exchanges such as the ASX, NYSE, Nasdaq and HKEX, without the need to own the underlying stock. You can even take advantage of market conditions when shares are trending in bearish territory.
*Share CFDs are not available on demo accounts.
Capital-infusions provides both new and experienced traders access to round-the-clock support, powerful platforms and useful educational resources. The advanced MT5 platform carries full EA (Expert Advisor) functionality and superior tools for comprehensive price analysis. Traders can also diversify their existing portfolios with access to over 300+ instruments including Forex, Commodities, Indices and more.
When you directly trade a share, you are buying and selling a small ownership of a publicly-listed company at prices determined by the market. Share CFDs differ in that they allow you to speculate on the share’s price without taking actual ownership of the underlying asset. This allows you to trade both long and short, whereas only long trading is available with standard share trading.
Additionally, because CFDs are leveraged products, you will only need to deposit a small portion of the full value of the trade in order to open a position. While this will increase any profits, it also means losses can exceed deposits. Standard share trading requires you to pay the full cost of your position upfront, so you cannot lose more than your investment.
Share CFDs are traded at the real market price. We take a small commission when you open the position, and then again when you close it. A breakdown of the costs associated with Share CFD trading with Capital-infusions is provided in the table below:
Country | Market Data Fee | Rebate Requirement | Commission Per Side |
Australia | AUD$22.00 | 4 Trades | 0.08%, with a minimum of AUD$7/HK$40/EUR$5/GBP$4/CHF$5/USD$5.5/NZD$7/CAD$7/SGD$7 |
USA | US$0.00 | 0 Trades | US$0.02 per share, with a minimum of US$10 |
Hong Kong | HK$120.00 | 4 Trades | 0.18%* with minimum of HK$50/AUD$10/EUR$6/GBP$6/CHF$7/USD$7/NZD$10/CAD$9/SGD$10 |
*During July 5, 2021 to July 31, 2021, minimum commission on HKEX CFDs will be discounted by 50% of account base currency standard rate or 20% of percentage commission.
Rebate requirement based on Share CFD trades of the specified country only. Market data fees are charged on 1st of every calendar month and reversed at the end of each calendar month if rebate requirement is met on a particular exchange.
To activate Share CFD data feeds, login to the Client Portal. Please note that you can only trade Share CFDs with Capital-infusions on the MetaTrader 5 platform.